Document is current
Any future updates will be listed below
-
Authors
Tešija, Katarina
Sredanović, Mašan
Jerčinović, Katy
Krbot Skorić, Magdalena
Habek, Mario https://orcid.org/0000-0002-3360-1748
-
Funding
Funding for this research was provided by:
Hrvatska Zaklada za Znanost (IP-2022-10-8200)
- License Information
-
More Information
Article History
Received: 3 February 2026
Accepted: 24 March 2026
First Online: 28 March 2026
Declarations
:
: KT: Nothing to disclose.MS: Nothing to disclose.KJ: Nothing to disclose.MKS: Received consultation and/or speaker fees from Biogen, Novartis, Roche, Merck.MH: Received consultation and/or speaker fees from Biogen, Merck, Novartis, Roche, Astra Zeneca, Amgen.
: After explaining the study procedures and allowing time for consideration, all participants provided written informed consent to participate. The ethical committees of the University Hospital Center Zagreb and the University of Zagreb, School of Medicine, approved the study protocol. The study adhered to the Declaration of Helsinki and the current European Regulation for Data Protection.
